Organigram Holdings Sees Robust Growth in Q3
Company Announcements

Organigram Holdings Sees Robust Growth in Q3

Story Highlights

OrganiGram Holdings (TSE:OGI) has released an update.

Organigram Holdings reports a significant increase in third-quarter fiscal 2024 net revenue, up 25% to $41.1 million, along with a positive adjusted EBITDA of $3.5 million, marking substantial growth over the previous year. The company also establishes a European presence through a strategic investment in Germany’s Sanity Group, enhancing its global market reach.

For further insights into TSE:OGI stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyBiotech Alert: Searches spiking for these stocks today
TipRanks Canadian Auto-Generated NewsdeskOrganigram Advances Global Cannabis Strategy with BAT Investment
TheFlyBiotech Alert: Searches spiking for these stocks today
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App